Archive for Medication updates
Discount Updates-June 2022
We have updated our Discount update page for June, Dispex Members can simply login for details. Takeda – From 1 July Prostap and Vipidia will no longer be available from Clarity. In...
Dame Lesley Regan appointed Women’s Health Ambassador
Source: Department of Health and Social Care 17th June 2022 Professor of Obstetrics and Gynaecology to drive system level changes to close the gender health gap Women’s Health Ambassador to...
Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29
Source: MHRA / Gov.uk 16th June 2022 Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping...
NICE sets out further details on menopause guideline update
Source: NICE 27th May 2022 NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed. The ‘scope’ of the...
Company led medicines recall: PCCA Limited, Ketamine 50mg in 5ml Oral Solution and Ketamine 100mg in 5ml Oral Solution (unlicensed medicines), CLMR (22)A/04
Source: MHR / Gov.uk PCCA Limited have been made aware of an issue with the appearance of Ketamine 50mg in 5ml Oral Solution and Ketamine 100mg in 5ml Oral Solution....
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenobarbital 60 mg Tablets, EL(22)A/28
Source: MHRA / Gov.uk 13.6.22 Bristol Laboratories Limited are recalling a batch of this product as a precautionary measure due to low dissolution test results reported during ongoing stability studies....
Discount Updates-June 2022
We have updated our Discount update page for June, Dispex Members can simply login for details. Takeda – From 1 July Prostap and Vipidia will no longer be available from Clarity. In...
Shortage of Hydrocortisone 2.5mg muco-adhesive buccal tablets
Source: SPS 6th June 2022 Medicines affected Medicines Supply Notification Number: MSN/2022/054 Medicine ...
Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27
Source: MHRA/ Gov.uk 1st June 2022 Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release...
Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27
Source: MHRA/ Gov.uk Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states...
Price Concessions Final Update-May 2022
Source: NHSBSA / DHSC Drug Tariff News – May Part VIIIA reimbursement prices (issued 31 May) The Department of Health and Social Care has agreed the May Drug Tariff Part...
Class 2 Medicines Recall: Quadrant Pharmaceuticals Ltd, Mefenamic Acid 500mg film coated tablets, EL (22)A/23
Source: MHRA / Gov.uk 17.5.22 Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer...
